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Background: Psorospermun aurantiacum and Hypericum lanceolatum are plants locally used in Cameroon and other
parts of Africa for the treatment of gastrointestinal and urinary tract infections, skin infections, venereal diseases,
gastrointestinal disorder, infertility, epilepsy as well as microbial infections. The present study was designed in order
to investigate the in vitro antimicrobial and radical scavenging activities of the extracts and isolated compounds
from the leaves of these plants.
Methods: The plant extract was prepared by maceration in ethyl acetate and methanol and fractionated by
column chromatography. The structures of isolated compounds were elucidated by spectroscopic analyses in
conjunction with literature data. The broth microdilution method was used to evaluate the in vitro antimicrobial
activity against bacteria, yeasts and dermatophytes. The antioxidant potentials of the extracts and their isolated
compounds were evaluated using the DPPH radical scavenging method.
Results: Five known compounds: physcion (1), 1,8-dihydroxy-3-geranyloxy-6-methylanthraquinone (2),
kenganthranol B (3), vismiaquinone (4), and octacosanol (5) were isolated from the leaves of P. aurantiacum while
six compounds including friedelin (6), betulinic acid (7), 2,2’,5,6’-tetrahydroxybenzophenone (8), allanxanthone A (9),
1,3,6- trihydroxyxanthone (10) and isogarcinol (11) were isolated from H. lanceolatum. Compound 8 and 4 exhibited
the highest antibacterial and antifungal activities with MIC ranges of 2–8 μg/ml and 4–32 μg/ml respectively.
P. aurantiacum crude extract (Rsa50 = 6.359 ± 0.101) showed greater radical scavenging activity compared with
H. lanceolatum extract (Rsa50 = 30.996 ± 0.879). Compound 11 showed the highest radical scavenging activity
(RSa50 = 1.012 ± 0.247) among the isolated compounds, comparable to that of L-arscobic acid
(RSa50 = 0.0809 ± 0.045).
Conclusions: The experimental findings show that the ethyl acetate and methanol extracts and isolated
compounds from P. aurantiacum and H. lanceolatum stem bark possess significant antimicrobial and antioxidant
activities justifying the use of these plants in traditional medicine, which may be developed as phytomedicines.* Correspondence: jrkuiate@yahoo.com
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During the last 20 years, it has been reported that
human infections are increasing at an alarming rate, es-
pecially in tropical and subtropical developing countries
[1]. This is partly due to the indiscriminate use of anti-
microbial drugs and the development of microbial resist-
ance to some of the synthetic drugs [2]. Resistance to
most antibiotics occurs through the aegis of extremely
efficient enzymes, efflux proteins and other transport
systems that often are highly specialized towards specific
antibiotic molecules [3]. The fact that microorganisms
nowadays tend to develop resistance towards drugs,
coupled to the undesirable side effects of certain antibio-
tics offer considerable potentials for the development of
new effective antimicrobial agents; medicinal plants
being a prolific source. Various plant extracts possess
bacteriostatic and bactericidal effects due to secondary
metabolites they contain, namely alkaloids, tannins, fla-
vonoids, and phenolic compounds. Most of these sec-
ondary metabolites other than possessing antimicrobial
potential, can also act as potent antioxidants [4].
Psorospermun aurantiacum and Hypericum lanceolatum
are trees, both belonging to the family of Guttiferae and are
generally found in mountainous areas [5]. In Cameroon,
Psorospermun aurantiacum appears in the North-West
and West Regions, where the decoction of the leaves is
used to treat gastrointestinal and urinary tract infections.
Combined with other plant extracts, the stem bark is used
to treat epilepsy. The fruits of this plant have been recently
investigated for their phytochemical constituents [6]. Hy-
pericum lanceolatum on the other hand, occurs on moun-
tains in the Western Region of Cameroon, and is used for
the treatment of skin infections, venereal diseases, gastro-
intestinal disorder, tumours, infertility and epilepsy [5,7].
Higher plants like those from the Guttiferae family are rich
sources of antimicrobial phenolic secondary metabolites
which are able to act as reducing agents, hydrogen donors,
and singlet oxygen quenchers [8-11].
Several antifungal [1], antibacterial [12,13], antican-
cer [14,15] and antiviral [16] compounds have been
isolated from Hypericum genus. In the present paper,
we report the isolation of constituents from Hypericum
lanceolatum and Psorospermun aurantiacum together with
some related antimicrobial and antioxidant activities of
these constituents and the crude extracts.
Methods
Plant material
The leaves of Psorospermum aurantiacum and Hypericum
lanceolatum were separately collected in May 2009 at
Mount Bamboutos, West Region of Cameroon.
Authentification of the plants was done by Mr. Nana
Victor at the Cameroon National Herbarium wherevoucher specimens were kept under the reference numbers
of 52651 HNC and 32356 HNC respectively.
Extraction, fractionation and isolation
The air-dried and powdered leaves of P. aurantiacum
(2.60 kg) and of H. lanceolatum (2.00 kg) were extracted
respectively with EtOAc and MeOH at room temperature
(3× 12 l, 72 h) to obtain corresponding crude extracts of
77 g and 60 g after evaporation under vacuum. The two
solvents were selected based on their extraction yields
from preliminary extractions studies. Part of the crude
extract of P. aurantiacum (67 g) was subjected to silica
gel column chromatography, eluted with gradients of
n-hexane-CH2Cl2 (10:0, 9:1, 8:2, 1:1; 0:10) and CH2Cl2-
MeOH (9:1, 8:2, 1:1; 0:10). Twenty three (23) fractions of
500 ml each were collected and grouped on the basis of
their thin layer chromatography (TLC) profiles into five
major fractions F1-F5 (F1: 1–4; F2: 5–8; F3: 9–14; F4:
15–20 and F5: 21–23). These fractions were submitted
to repeated column chromatography over silica gel and
purified by preparative TLC. Octacosanol (10 mg) was
obtained from fraction F1. Fractions F2 and F3
afforded 1,8-dihydroxy-3-geranyloxy-6- methylanthra-
quinone (8 mg) and vismiaquinone (11 mg) respect-
ively. Fraction F4 afforded kenganthranol B (10 mg)
and physcion (25 mg).
Fifty-five grams (55 g) of the crude extract of H.
lanceolatum was subjected to silica gel column chroma-
tography eluted with gradients of n-hexane-EtOAc (10:0,
9:1, 8:2, 1:1; 0:10) and EtOAc-MeOH (9:1, 8:2, 1:1; 0:10).
Thirty-eight fractions of 500 ml each were collected and
combined on the basis of TLC analysis to afford five
main fractions (A–E). Fraction A contained mostly fatty
materials and was not further investigated. Fraction B
was further separated by silica gel column chromatog-
raphy eluted with n-hexane-EtOAc to give white needles
of friedelin (14 mg). Betulinic acid (1.2 g) was purified
from fraction C by recrystallization in MeOH. Fraction
D was submitted to a silica gel column chromatography
eluted with n-hexane-EtOAc to afford three sub-
fractions (D1-D3). Sub-fraction D1 was further purified
by Sephadex LH-20 using CH2Cl2-MeOH (1:1) to give
2,2’,5,6’-tetrahydroxybenzophenone (30 mg). Repeated col-
umn chromatography of sub-fraction D2 on silica gel
using increasing mixtures of n-hexane-EtOAc yielded
allanxanthone A (16 mg) and 1,3,6-trihydroxyxanthone
(7 mg). Isogarcinol (18 mg) was purified from sub- frac-
tion D3 by recrystallization in n-hexane.
Identification of isolated compounds
The structural elucidation of compounds was done on
the basis of physical data and spectroscopic analysis, in-
cluding 1D and 2D NMR and direct comparison of the
data with those reported in the literature. Melting points
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corrected. UV spectra were measured with a UV-210
PC, UV/Vis scanning spectrophotometer (Analytikjena).
IR spectra were recorded on a Shimadzu FTIR-8400S
spectrophotometer with KBr. EIMS (ionization voltage
70 eV) and HREIMS mass spectra were recorded on Jeol
JMS AX-500 and AX-700 or a 6890 N Network GC Sys-
tem/5975 Inert XL Mass Selective Detector GCMS spec-
trometers. 1H NMR (500 MHz) and 13C NMR
(125 MHz) spectra were recorded in CDCl3 or CDCl3-
CD3OD using a Bruker Avance 500 MHz spectrometer.
Silica gel 60 (70–230; Merck; Darmstadt, Germany) was
used for column chromatography. Precoated Silica gel
60 Kieselgel F254 plates (0.2 mm thick) were used for
TLC, and the spots were detected with ultraviolet (UV)
illumination and by spraying with 50% (v/v) H2SO4, fol-
lowed by heating at 100°C. Merck Silica gel 60 F254 was
used for preparative thin layer chromatography.Antimicrobial assay
Microorganisms and culture media
The microorganisms used in this study were obtained
from the American Type Culture Collection (ATCC),
“Ecole Nationale Vétérinaire d’Alfort” (E), “Institut Pas-
teur de Paris” (IP) and “Centre Pasteur de Yaoundé”.
They included five bacteria species (Klebsiella pneumonia
ATCC 13883, Pseudomonas aeruginosa ATCC 27853, Shi-
gella flexneri, Salmonella typhi ATCC 6539 and Entero-
coccus faecalis ATCC 10541) and six fungal species
(Candida lusitaniae ATCC 200950, Candida krusei ATCC
6258, Candida albicans ATCC 2091, Cryptococcus neofor-
mans IP 95026,Trichophyton ajelloi,Trichophyton rubrum).
The culture medium, Sabouraud Dextrose Agar (SDA,
Conda), was used for subculturing during minimum fungi-
cidal concentration determination. Sabouraud Dextrose
Broth (SDB, Conda) was used for the determination of
minimum inhibitory and fungicidal concentrations.Preparation of microbial inocula
The inocula of bacteria and yeasts were prepared from
24 h old broth cultures. The absorbance was read at
600 nm and adjusted with sterile physiological solution
to match that of a 0.5 McFarland standard solution.
From the prepared microbial solutions, other dilutions
with sterile physiological solution were prepared to give
a final concentration of 106 colony- forming units (CFU)
per milliliter for bacteria and 2 × 105 spores per milliliter
for yeasts.
Conidia suspensions of dermatophyte species were
prepared after separation and filtration of conidia from
15 days old cultures. The number of conidia was deter-
mined using a spectrophotometer and adjusted with
sterile physiological solution to an absorbance of 0.60 at450 nm corresponding to a final concentration of 1 × 105
spores/ml [17].
Determination of minimum inhibitory concentration (MIC)
and minimum microbicidal concentrations (MMC)
The MICs of the crude extract and isolated compounds
were determined by the broth microdilution method in
96-well micro-titre plates as described by Zgoda et Poter
(2001) [18]. The 96-well plates were prepared by dis-
pensing into each well 100 μl of Mueller Hinton broth
for bacteria and Sabouraud Dextrose broth for fungi.
The test substances were initially prepared in 10%
DMSO in broth medium at 4096 μg/ml for the extracts
and 512 μg/ml for compounds or 50 μg/ml for the refer-
ence antibiotics. A volume of 100 μl of each test sample
was added into the first wells of the micro-titre plate
(whose wells were previously loaded with 100 μl of broth
medium). Serial two-fold dilutions of the test samples were
made and 100 μl of inoculum standardized at 106 CFU/ml
for bacteria, 2.5× 105 CFU/ml for yeasts (at 600 nm, Jenway
6105 UV/Vis spectrophotometer- 50 Hz/60 Hz) [19] and
1×105 spores/ml for dermatophytes (at 450 nm) were then
added into each well. This gave final concentration ranges
of 1024 to 0.5 μg/ml for the extracts, 128 to 0.0625 μg/ml
for isolated compounds and 12.50 to 0.006 μg/ml for refer-
ence substances. The plates were sealed with parafilm, then
agitated with a plate shaker to mix their contents and incu-
bated at 35°C for 24 h for bacteria, 48 h for yeast and at 28°
C for 5 days for dermatophytes.
For bacteria, MICs were determined upon addition of
50 μl (0.2 mg/ml) p-iodonitrotetrazolium chloride (INT,
Sigma-Aldrich, South Africa). Viable bacteria reduced
the yellow dye to a pink colour. For yeasts and dermato-
phytes, MICs were determined by visualising the turbid-
ity of the wells. The MIC corresponded to the lowest
well concentration where no colour/turbidity change
was observed, indicating no growth of microorganism.
The MBC or MFC was determined by transferring 50 μl
aliquots of the clear wells into 150 μl of freshly prepared
broth medium and incubating at 35°C for 24 h
(bacteria), 48 h (yeasts) and at 28°C for 5 days (derma-
tophytes). The MBC or MFC was regarded as the low-
est concentration of test sample which did not produce
a colour/turbidity change as above, indicating no micro-
bial growth. All tests were performed in triplicates.
Ciprofloxacin for bacteria, nystatin for yeast and griseo-
fulvin for dermatophytes were used as positives con-
trols.
Antioxidant activity
Radical scavenging activity (RSa) of the extract and pure
compounds from P. aurantiacum was determined using
the stable free radical 2,2’-diphenylpicrylhydrazyl (DPPH)
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lution was made from a 625 μg/ml stock solution of each
sample to obtain concentration ranges of 625 to 78.12 μg/
ml. A quantity of (100 μl) of each test solution was mixed
with 900 μl of a freshly prepared DPPH-methanol solution
(20 mg/l) and allowed to stand for 30 min in the dark at
room temperature. The optical densities of the resulting
solutions were read at 517 nm using a Jenway UV/vis 6105
spectrophotometer. L-ascorbic acid was used as positive
control. Radical scavenging activity (RSa) was calculated as
follows:
%RSa ¼ Absorbance of DPPH  Absorbance of sample
Absorbance of DPPH
 100Figure 1 Chemical structures of physcion (1), 1,8 dihydroxy-3-geranyl
vismiaquinone (4), octacosanol (5) from P. aurantiacum and friedelin
allanxanthone A (9); 1,3,6-trihydroxyxanthone (10); Isogarcinol (11) frSample concentration providing 50% radical scaven-
ging activity (RSa50) was calculated from the graph
of %RSa as a function of log [sample concentration].Statistical analysis
The data on antioxidant activity were subjected to the
one-way analysis of variance (ANOVA) and results were
expressed (where appropriate) as mean± standard devi-
ation. Differences between means of samples were com-
pared using Duncan’s multiple range tests at P< 0.05.Results and discussion
The following known compounds: physcion (1) [21], 1,8-
dihydroxy-3-geranyloxy-6- methylanthraquinone (2) [22],oxy-6-methylanthraquinone (2), kenganthranol B (3),
(6); Betulinic acid (7); 2,2’,5,6’-tetrahydroxybenzophenone (8);
om H. lanceolatum.
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octacosanol (5) [24] (Figure 1) were isolated and
identified in the leaves of P. aurantiacum. From the MeOH
leaf- extract of H. lanceolatum friedelin (6) [11], betulinic
acid (7) [25], 2,2’,5,6’- tetrahydroxybenzophenone (8) [7],
allanxanthone A (9) [26], 1,3,6-trihydroxyxanthone (10)
[27] and isogarcinol (11) [28] were isolated and identifiedTable 1 Minimum inhibitory concentration (MIC)/Minimum ba
tests substances (μg/ml)
P. aurantiacum
Parameters Extracta 1 2 3
Bacteria
K. pneumoniae MIC 256 - 16 128
MBC 1024 - 32 128
MBC/MIC 4 - 2 1
S. flexneri MIC 1024 - 64 -
MBC >1024 - 64 -
MBC/MIC nd - 1 -
P. aeruginosa MIC 1024 - 32 -
MBC >1024 - 64 -
MBC/MIC nd - 2 -
S. typhi MIC - - - -
MBC nd nd nd nd
MBC/MIC nd nd nd nd
E. faecalis MIC - - - -
MBC nd nd nd nd
MBC/MIC nd nd nd nd
Fungi/ Yeats
C. albicans MIC 1024 - - -
MBC >1024 nd nd nd
MBC/MIC nd nd nd nd
C. lusitaniae MIC 256 16 8 8
MBC 256 16 32 16
MBC/MIC 1 1 4 2
C. neoformans MIC 1024 16 - -
MBC 1024 16 nd nd
MBC/MIC 1 1 nd nd
C. krusei MIC 1024 64 - -
MBC 1024 64 nd nd
MBC/MIC 1 1 nd nd
Fungi/Dermatophytes
T. ajelloi MIC 1024 16 16 4
MBC 1024 16 16 4
MBC/MIC 1 1 1 1
T. rubrum MIC 1024 32 128 16
MBC 1024 32 128 16
MBC/MIC 1 1 1 1
Extracta : EtOAc extract of the leaves of P. aurantiacum; Extractb : MeOH extract of t
concentration up to 128 μg/ml for compounds and 1024 μg/ml for extracts; RD (Re
dermatophytes.(Figure 1). The compounds isolated in the present study
were formerly isolated from other plants and diverse activ-
ities were demonstrated. H. lanceolatum extract and its iso-
lated compounds have been proven to possess anti-malarial
properties [29].
The antimicrobial properties of the extracts and iso-
lated compounds of P. aurantiacum and H. lanceolatumctericidal or fungicidal concentration (MBC or MFC) of
H. lanceolatum
4 5 Extractb 7 10 11 RD
8 4 64 125 4 16 1
16 - 1024 - 4 16 1
2 - 16 - 1 1 1
16 8 64 2 8 16 0.50
16 8 1024 2 8 16 0.50
1 1 16 1 1 1 1
8 - 64 - 8 16 1
16 - 1024 - 8 16 1
2 - 16 - 1 1 1
- 2 32 2 2 4 0.50
nd 2 1024 2 2 4 0.50
nd 1 32 1 1 1 1
nd 32 64 32 8 32 0.50
nd 32 1024 32 8 32 0.50
nd 1 16 1 1 1 1
32 - 512 - 32 64 2
32 - 1024 - 32 64 2
1 - 2 - 1 1 1
4 - - - - - 1
8 - nd - nd nd 1
2 nd - nd nd 1
32 125 512 - 32 64 0.5
64 125 1024 - 32 64 1
2 1 2 - 1 1 2
32 - 256 - 64 64 2
32 - 1024 - 64 64 2
1 - 4 - 1 1 1
4 4 512 4 32 64 4
4 4 1024 4 32 64 4
1 1 2 1 1 1 1
8 32 256 64 8 32 4
8 32 1024 64 8 32 4
1 1 4 1 1 1 1
he leaves of H. lanceolatum; nd: not determined; -: not active at the
ference drug) ciprofloxacin for bacteria, nystatin for yeast and griseofulvin for
Table 2 Radical Scavenging activity 50 values (μg) of the
methanol extracts and compounds from the leaves of H.
Lanceolatum and P. aurantiacum
Test substance Rsa50 (μg)
H. lanceolatum extract 30.99 ± 0.87e P.
aurantiacum extract 6.35 ± 0.10b,c
Isogarcinol 1.01 ± 0.24b
1,3,6-trihydroxyxanthone 4.73 ± 0.80b





L-ascorbic acid 0.089 ± 0.05a
Values with the same letter superscripts are not significantly different using
Waller Duncan test at p≤ 0.05. na: not active.
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H. lanceolatum presented a wide range of activity and
was more active than that of P. aurantiacum. Isogarcinol
(11) and octacosanol (5) were the most active com-
pounds with relatively high antibacterial activities, par-
ticularly on S. flexneri, K. pneumoniae and S. typhi while
physcion (1) showed virtually no antimicrobial activity at
the tested concentrations on bacteria. This is interesting
in the perspective of developing more potent antibacter-
ial agents especially when regarding the global diseases
burden of the susceptible microorganisms [30,31]. Iso-
garcinol, a benzophenone derivative is known to possess
cytotoxic effect [32].
In general, the antifungal activities of isolated com-
pounds were relatively lower than their antibacterialFigure 2 DPPH radical scavenging activities of crude extracts and comactivities. However, kenganthranol B (3), vismiaquinone
(6), octacosanol (7) and betulinic acid (9) showed rela-
tively high antidermatophytic activity particularly on T.
ajelloi. Mbaveng et al. (2008) [33] previously demon-
strated the antimicrobial properties of vismiaquinone
isolated from Vismia guineensis and this corroborate the
present study. The results obtained with kenganthranol
B corroborate those of Kouam et al. (2006) [34] who
reported that kenganthranol E possess no antibacterial
activity against Bacillus megaterium, Escherichia coli,
Chlorella fusca and Microbotryum violaceum. Despite
the relatively low antimicrobial activity of kenganthranol
B, it has demonstrated, together with some of its iso-
mers, to possess alpha-glucosidase inhibitory activity
[34]. All the isolated compounds were generally less ac-
tive than the reference antibiotics. The ratio MBC/MIC
was generally ≤ 4 with respect to all the microorganisms
studied, indicative of a possible bactericidal nature of the
test samples [35].
Many microbial infections lead to the production of
highly reactive molecules from the metabolism of oxy-
gen that can cause extensive damage to cells and tissues
[36]. The extracts and isolated compounds exhibited dif-
ferential radical scavenging activity against the stable
DPPH free radical (Table 2 and Figure 2). At high con-
centrations (12.5 -50 μg/ml) the activity of isogarcinol
was comparable to that of L-ascorbic acid, the reference
molecule. Although isogarcinol was isolated from H.
lanceolatum, the crude extract of this plant showed a
relatively low activity compared to that of P. aurantiacum.
This may either be due to low concentration of this com-
pound in the extract or to an antagonistic effect with other
constituents of the extract. Isogarcinol is an isomeric formpounds from P. aurantiacum and H. lanceolatum.
Tchakam et al. BMC Complementary and Alternative Medicine 2012, 12:136 Page 7 of 8
http://www.biomedcentral.com/1472-6882/12/136of garcinol, known to possess high antioxidant activity
among many other properties [37].
Conclusion
The present findings support the ethno-pharmacological
exploitation of these plants in the treatment of microbial
infections and hold great perspective in the development
of alternative antimicrobial and antioxidant agents from
isogarcinol.
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